Literature DB >> 5299945

Mechanisms of activation of C'1 esterase in hereditary angioneurotic edema plasma in vitro.

V H Donaldson.   

Abstract

The generation of C'1 esterase activity in siliconed plasma obtained from individuals with hereditary angioneurotic edema in remission tends to occur spontaneously, but can be hastened during its incubation with preparations of activated Hageman factor. This effect of activated Hageman factor could not be shown during its incubation with normal siliconed plasma, nor could consumption of normal serum inhibition of C'1 esterase be clearly shown. Soy bean trypsin inhibitor and heparin could impair this enhanced generation of C'1 esterase but neither inhibits the esterolytic function of C'1 esterase once formed. Trasylol was less effective in blocking this effect of activated Hageman factor. While the mechanism of the effect of activated Hageman factor upon C'1 activation remains obscure, it is apparent that some intermediate steps, possibly involving a kinin-forming system of plasma, may play a role.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5299945      PMCID: PMC2138464          DOI: 10.1084/jem.127.3.411

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  39 in total

1.  ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID.

Authors:  O D RATNOFF; J D CRUM
Journal:  J Lab Clin Med       Date:  1964-03

2.  WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING.

Authors:  E W DAVIE; O D RATNOFF
Journal:  Science       Date:  1964-09-18       Impact factor: 47.728

3.  ACTION OF COMPLEMENT IN HEREDITARY ANGIONEUROTIC EDEMA: THE ROLE OF C'1-ESTERASE.

Authors:  V H DONALDSON; F S ROSEN
Journal:  J Clin Invest       Date:  1964-11       Impact factor: 14.808

4.  Relationship between air temperature and mean radiant temperature in thermal comfort.

Authors:  W KOCH
Journal:  Nature       Date:  1962-11-10       Impact factor: 49.962

5.  The purification of activated Hageman factor (activated factor XII).

Authors:  O D RATNOFF; E W DAVIE
Journal:  Biochemistry       Date:  1962-11       Impact factor: 3.162

6.  Action of the kallikreins on synthetic ester substrates.

Authors:  M E WEBSTER; J V PIERCE
Journal:  Proc Soc Exp Biol Med       Date:  1961-05

7.  Hagerman factor and capillary permeability.

Authors:  J MARGOLIS
Journal:  Aust J Exp Biol Med Sci       Date:  1959-06

8.  Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition.

Authors:  O D RATNOFF; J M ROSENBLUM
Journal:  Am J Med       Date:  1958-08       Impact factor: 4.965

9.  INHIBITION OF beta HEMOLYTIC STREPTOCOCCI FIBRINOLYSIN BY TRYPSIN INHIBITOR (ANTIPROTEASE).

Authors:  I A Mirsky
Journal:  Science       Date:  1944-09-01       Impact factor: 47.728

10.  The conversion of C'IS to C'1 esterase by plasmin and trypsin.

Authors:  O D Ratnoff; G B Naff
Journal:  J Exp Med       Date:  1967-02-01       Impact factor: 14.307

View more
  27 in total

1.  The enhancement of the haemolytic activity of the first component of complement by trasylol.

Authors:  J M Delage; J Simard; G Lehner-netsch
Journal:  Immunology       Date:  1976-10       Impact factor: 7.397

2.  Turnover of human and monkey plasma kininogens in rhesus monkeys.

Authors:  T Yamada; D A Wing; J V Pierce; G W Pettit
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

Review 3.  Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.

Authors:  Allen P Kaplan; Kusumam Joseph
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

4.  C-1 inhibitor activity levels in active rheumatoid and psoriatic arthritis.

Authors:  M Maqaro; L Altomonte; A Zoli; L Mirone; M Berchicci; G Corvino
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

5.  C-reactive protein-mediated complement activation in polymyalgia rheumatica and other systemic inflammatory diseases.

Authors:  P Vaith; G M Hänsch; H H Peter
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

6.  C1 inactivator inhibition by plasmin.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

7.  In vitro activation of C1s in plasma of patients with hereditary angioneurotic oedema.

Authors:  S Shafiasghar; R H Cormane; K W Pondman
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

8.  Human plasma kallikrein releases neutrophil elastase during blood coagulation.

Authors:  Y T Wachtfogel; U Kucich; H L James; C F Scott; M Schapira; M Zimmerman; A B Cohen; R W Colman
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

9.  Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization.

Authors:  V H Donaldson; O D Ratnoff; W Dias Da Silva; F S Rosen
Journal:  J Clin Invest       Date:  1969-04       Impact factor: 14.808

10.  Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.

Authors:  A de Agostini; H R Lijnen; R A Pixley; R W Colman; M Schapira
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.